Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Hepatol ; 15(5): 662-72, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27493104

RESUMO

 Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the third leading cause of cancer related death worldwide. In recent years, the prevalence of HCC has increased in both developing and developed countries. Most HCC cases develop in the presence of advanced chronic liver disease related to viral hepatitis. In particular hepatitis B virus and hepatitis C virus infections are considered as major HCC risk factors worldwide. However, current studies provide strong evidence for increasing numbers of HCC in nonalcoholic fatty liver disease (NAFLD). NAFLD represents the hepatic manifestation of metabolic syndrome which is based on obesity and insulin resistance. Epidemiologic data clearly demonstrates that NAFLD and obesity-related disorders are significant risk factors for tumor development in general and HCC in particular. As a consequence of life style changes towards higher calorie intake and less exercise, obesity and metabolic syndrome are spreading all over the world. Due to this increase in obesity and metabolic syndrome NAFLD-related HCC will become a major health care problem in the future. In conclusion, better understanding of the impact of NAFLD and obesity in the development of HCC will improve our treatment strategies of HCC and allow preventive measures.


Assuntos
Carcinoma Hepatocelular/epidemiologia , Países em Desenvolvimento/economia , Desenvolvimento Econômico , Neoplasias Hepáticas/epidemiologia , Obesidade/epidemiologia , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/economia , Dieta/efeitos adversos , Dieta/economia , Ingestão de Energia , Humanos , Resistência à Insulina , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/economia , Síndrome Metabólica/economia , Síndrome Metabólica/epidemiologia , Hepatopatia Gordurosa não Alcoólica/economia , Hepatopatia Gordurosa não Alcoólica/epidemiologia , Obesidade/diagnóstico , Obesidade/economia , Prevalência , Prognóstico , Medição de Risco , Fatores de Risco , Comportamento Sedentário , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...